Načítá se...
Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women
Studies of tenofovir disoproxil fumarate (TDF)-emtricitabine (FTC)–based preexposure prophylaxis (PrEP) have not focused on transgendered women who are at disproportionate risk of HIV acquisition. Concerns exist for drug interactions between cross-sex therapy (estradiol, progestins, and spironolacto...
Uloženo v:
| Vydáno v: | J Acquir Immune Defic Syndr |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
JAIDS Journal of Acquired Immune Deficiency Syndromes
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4955879/ https://ncbi.nlm.nih.gov/pubmed/27429188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000001105 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|